The Busan Regional CardioCerebroVascular Center Project's Experience Over a Decade in the Treatment of ST-segment

Kyunghee Lim1, Hyeyeon Moon2, Jong Sung Park1

  • 1Department of Cardiology, Busan Regional CardioCerebroVascular Center, Dong-A University Hospital, Busan, Korea.

Insights

The Busan Regional CardioCerebroVascular Center project improved ST-segment elevation myocardial infarction (STEMI) treatment times but did not alter survival outcomes. Increased false-positive percutaneous coronary intervention (PCI) team activations were noted.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Public Health Initiatives

Background:

  • The Regional CardioCerebroVascular Center (RCCVC) project aimed to enhance acute myocardial infarction and stroke care in non-capital Korean regions.
  • This study specifically evaluates the impact of the Busan RCCVC project on ST-segment elevation myocardial infarction (STEMI) treatment.

Purpose of the Study:

  • To assess the outcomes and identify challenges of the Busan RCCVC project in managing STEMI.
  • To evaluate the effectiveness of the RCCVC initiative in improving patient care for STEMI.

Main Methods:

  • Analysis of 1161 STEMI patients undergoing percutaneous coronary intervention (PCI) at the Busan RCCVC.
  • Comparison of data from 2007-2019 with a historical cohort to evaluate changes over time.

Main Results:

  • Median door-to-balloon time decreased from 86 to 54 minutes; symptom-to-balloon time reduced from 256 to 189 minutes (p<0.001).
  • False-positive PCI team activation rate increased significantly from 0.6% to 21.4% (p<0.001).
  • One-year rates of cardiovascular death and major adverse cardiac events remained unchanged; many patients still experienced delays or inter-hospital transfers.

Conclusions:

  • The Busan RCCVC project successfully reduced reperfusion times for STEMI patients over a decade.
  • Despite improved time metrics, survival outcomes for STEMI patients did not significantly change.
  • The initiative led to a higher rate of false-positive PCI team activations without a corresponding improvement in mortality or major adverse cardiac events.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
25
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
68
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30